
KMC Speciality (KMCSHIL) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
665.5M
Gross Profit
561.9M
84.43%
Operating Income
113.7M
17.08%
Net Income
75.4M
11.32%
EPS (Diluted)
₹0.46
Balance Sheet Metrics
Total Assets
2.9B
Total Liabilities
1.2B
Shareholders Equity
1.6B
Debt to Equity
0.74
Cash Flow Metrics
Revenue & Profitability Trend
KMC Speciality Income Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Revenue | 2.3B | 1.8B | 1.5B | 1.4B | 1.0B |
Cost of Goods Sold | 336.8M | 244.2M | 229.7M | 205.6M | 163.2M |
Gross Profit | 2.0B | 1.5B | 1.3B | 1.1B | 855.6M |
Gross Margin % | 85.5% | 86.1% | 85.2% | 84.8% | 84.0% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | - | 452.2M | 413.8M | 337.1M | 287.0M |
Other Operating Expenses | 891.5M | 201.3M | 172.6M | 162.6M | 114.0M |
Total Operating Expenses | 891.5M | 653.4M | 586.4M | 499.8M | 401.0M |
Operating Income | 379.3M | 392.1M | 344.3M | 311.3M | 179.2M |
Operating Margin % | 16.4% | 22.2% | 22.2% | 23.0% | 17.6% |
Non-Operating Items | |||||
Interest Income | - | 20.3M | 17.7M | 12.5M | 8.9M |
Interest Expense | 94.2M | 11.6M | 8.1M | 7.0M | 9.5M |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | 316.0M | 405.6M | 359.9M | 321.0M | 180.4M |
Income Tax | 101.8M | 101.8M | 93.0M | 83.7M | 52.6M |
Effective Tax Rate % | 32.2% | 25.1% | 25.8% | 26.1% | 29.2% |
Net Income | 214.3M | 303.8M | 266.9M | 237.3M | 127.8M |
Net Margin % | 9.3% | 17.2% | 17.2% | 17.5% | 12.5% |
Key Metrics | |||||
EBITDA | 599.7M | 515.8M | 448.8M | 394.9M | 257.6M |
EPS (Basic) | ₹1.31 | ₹1.86 | ₹1.64 | ₹1.45 | ₹0.78 |
EPS (Diluted) | ₹1.31 | ₹1.86 | ₹1.64 | ₹1.45 | ₹0.78 |
Basic Shares Outstanding | 163565649 | 163085000 | 163085000 | 163085000 | 163085000 |
Diluted Shares Outstanding | 163565649 | 163085000 | 163085000 | 163085000 | 163085000 |
Income Statement Trend
KMC Speciality Balance Sheet From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 91.9M | 48.5M | 18.4M | 16.7M | 21.3M |
Short-term Investments | 127.9M | 178.3M | 369.5M | 314.9M | 155.7M |
Accounts Receivable | 59.8M | 43.8M | 43.7M | 35.4M | 25.5M |
Inventory | 35.0M | 20.5M | 22.7M | 18.7M | 17.5M |
Other Current Assets | 15.2M | 12.5M | 18.3M | 11.5M | 11.3M |
Total Current Assets | 332.4M | 335.2M | 518.6M | 424.8M | 261.3M |
Non-Current Assets | |||||
Property, Plant & Equipment | 2.5B | 738.5M | 423.0M | 345.8M | 313.0M |
Goodwill | 441.0K | 648.0K | 3.9M | 8.0M | 5.0M |
Intangible Assets | 441.0K | 648.0K | 3.9M | 8.0M | 5.0M |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 1.6M | 600 | 6.0K | 6.0K | 971.0K |
Total Non-Current Assets | 2.5B | 2.3B | 1.3B | 862.9M | 788.6M |
Total Assets | 2.9B | 2.6B | 1.8B | 1.3B | 1.0B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 140.8M | 75.6M | 64.1M | 54.1M | 52.1M |
Short-term Debt | 116.0M | 103.4M | 55.1M | 76.3M | 14.8M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 42.1M | 14.5M | 12.2M | 9.5M | 6.3M |
Total Current Liabilities | 379.4M | 464.5M | 225.4M | 195.1M | 125.6M |
Non-Current Liabilities | |||||
Long-term Debt | 778.5M | 714.8M | 444.3M | 211.5M | 275.6M |
Deferred Tax Liabilities | 32.8M | 6.4M | 0 | 597.0K | 5.8M |
Other Non-Current Liabilities | 1.0M | 811.0K | 802.0K | 1.1M | - |
Total Non-Current Liabilities | 837.3M | 736.8M | 456.1M | 224.5M | 291.0M |
Total Liabilities | 1.2B | 1.2B | 681.5M | 419.6M | 416.6M |
Equity | |||||
Common Stock | 163.1M | 163.1M | 163.1M | 163.1M | 163.1M |
Retained Earnings | - | 1.3B | 978.7M | 711.8M | 474.5M |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 1.6B | 1.4B | 1.1B | 868.0M | 633.3M |
Key Metrics | |||||
Total Debt | 894.5M | 818.2M | 499.4M | 287.8M | 290.4M |
Working Capital | -47.0M | -129.3M | 293.1M | 229.7M | 135.6M |
Balance Sheet Composition
KMC Speciality Cash Flow Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 316.0M | 405.6M | 359.9M | 237.3M | 127.8M |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | - | - | - | - | - |
Working Capital Changes | -39.1M | -15.7M | -27.2M | -4.3M | 24.7M |
Operating Cash Flow | 362.5M | 381.2M | 323.1M | 227.5M | 153.1M |
Investing Activities | |||||
Capital Expenditures | -638.7M | -752.4M | -441.0M | -134.8M | -408.2M |
Acquisitions | - | - | - | - | - |
Investment Purchases | - | - | -55.5M | -160.5M | -67.0M |
Investment Sales | - | - | - | - | - |
Investing Cash Flow | -638.7M | -752.4M | -496.5M | -294.6M | -475.2M |
Financing Activities | |||||
Share Repurchases | - | - | - | - | - |
Dividends Paid | - | - | - | - | - |
Debt Issuance | 186.8M | 355.7M | 191.4M | 13.4M | 229.6M |
Debt Repayment | -91.6M | -76.7M | -15.2M | -14.1M | -37.7M |
Financing Cash Flow | 95.3M | 279.0M | 176.2M | -618.0K | 191.9M |
Free Cash Flow | -63.0M | -368.5M | -117.9M | 156.4M | -152.5M |
Net Change in Cash | -180.9M | -92.2M | 2.9M | -67.7M | -130.1M |
Cash Flow Trend
KMC Speciality Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
48.64
Price to Book
7.09
Price to Sales
4.63
PEG Ratio
1.38
Profitability Ratios
Profit Margin
9.57%
Operating Margin
17.08%
Return on Equity
13.04%
Return on Assets
7.49%
Financial Health
Current Ratio
0.88
Debt to Equity
54.43
Beta
-0.17
Per Share Data
EPS (TTM)
₹1.43
Book Value per Share
₹9.81
Revenue per Share
₹14.94
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
kmcshil | 11.3B | 48.64 | 7.09 | 13.04% | 9.57% | 54.43 |
Max Healthcare | 1.2T | 105.26 | 12.80 | 11.47% | 15.27% | 32.09 |
Apollo Hospitals | 1.1T | 72.46 | 13.87 | 16.71% | 6.98% | 90.89 |
Indraprastha Medical | 42.1B | 25.12 | 7.07 | 26.98% | 12.21% | 5.49 |
Shalby | 21.3B | 1,122.67 | 1.95 | 0.63% | -0.05% | 47.82 |
Dr. Agarwal's Eye | 23.1B | 40.00 | 11.04 | 26.07% | 13.96% | 158.94 |
Financial data is updated regularly. All figures are in the company's reporting currency.